Literature DB >> 9597119

Regional brain serotonin receptor changes in portacaval shunted rats.

G Apelqvist1, P B Bergqvist, B Larsson, M Bugge, F Bengtsson.   

Abstract

The pathogenesis of hepatic encephalopathy is unknown, but metabolic perturbations, including hyperammonaemia and increased brain turnover of serotonin (5-HT), have been identified. Possible alterations of 5-HT receptors in the brain have been rudimentarily studied. We therefore investigated the 5-HT1A, 5-HT1B and 5-HT2A receptor density in 18-22 different regions in the brain of portacaval shunted rats by means of radioligand binding with autoradiographical evaluation. The results revealed a decreased 5-HT1A receptor binding in seven serotonergic projection areas of the brain, and an increase in the nucleus accumbens, hypothalamus and subiculum. No changes in the raphe nuclei were observed. An increased 5-HT1B receptor binding was seen in five brain regions: basal ganglia, olfactorial regions, hippocampus, mid brain and thalamus. However, decreased binding was seen in three regions of cortical areas and hippocampus. The 5-HT2A receptor binding site density was essentially unaltered. These findings suggest that perturbations in the central serotonergic neurotransmission may play a functional role in chronic hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597119     DOI: 10.1046/j.1365-201X.1998.0310f.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  2 in total

1.  Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation.

Authors:  I Magen; Y Avraham; Z Ackerman; L Vorobiev; R Mechoulam; E M Berry
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

Review 2.  The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.

Authors:  Zefeng Chen; Jingsheng Ruan; Dinghua Li; Min Wang; Zhiwei Han; Wenxia Qiu; Guobin Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.